STOCKWATCH
·
Biotechnology: Pharmaceutical Preparations
Corporate ActionMay 14, 2026, 04:33 PM

GH Research to Offer Up to $200M in At-the-Market Equity Offering

AI Summary

GH Research PLC has entered into an At-the-Market Equity Offering Sales Agreement with Stifel, Nicolaus & Company, Incorporated. This agreement allows the company to offer and sell up to $200 million of its ordinary shares from time to time through Stifel, acting as a sales agent or principal. The offering has been registered under the Securities Act.

Key Highlights

  • GH Research PLC entered into an At-the-Market Equity Offering Sales Agreement with Stifel, Nicolaus & Company, Incorporated.
  • The company plans to offer and sell up to $200 million of ordinary shares.
  • The ordinary shares have a nominal value of $0.025 per share.
  • Stifel, Nicolaus & Company, Incorporated will act as sales agent or principal.
  • The offering is registered under the Securities Act via a registration statement on Form F-3 (File No. 333-285310).
GHRS
Biotechnology: Pharmaceutical Preparations
GH Research PLC

Price Impact